Bio-Rad Laboratories Reliance SARS-CoV-2/FluA/FluB RT-PCR and Reliance SARS-CoV-2 RT-PCR Assay Kits have been granted emergency use authorization by the U.S. Food and Drug Administration. The multitarget Reliance SARS-CoV-2/FluA/FluB RT-PCR Assay Kit simultaneously detects and differentiates SARS-CoV-2 (the virus associated with COVID-19), influenza A, and influenza B in a single, multiplex reaction. The highly sensitive respiratory pathogen panel is intended for use with nasopharyngeal swabs and anterior nasal swabs. Bio-Rad s Reliance SARS-CoV-2 RT-PCR Assay Kit is a multiplex test that targets two separate regions in the nucleocapsid gene (N1 and N2 regions) to ensure greater sensitivity and tolerance to potential mutations that may occur within the viral genome over time in the detection of SARS-CoV-2. Both assay kits contain the company s standard and negative molecular controls and are validated to run on the CFX Opus 96, CFX96 Touch, and CFX96 Dx qPCR Systems, and for higher-